Martin C. Chang

3.7k total citations
67 papers, 2.2k citations indexed

About

Martin C. Chang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Martin C. Chang has authored 67 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 22 papers in Oncology and 21 papers in Cancer Research. Recurrent topics in Martin C. Chang's work include Breast Cancer Treatment Studies (16 papers), HER2/EGFR in Cancer Research (11 papers) and BRCA gene mutations in cancer (6 papers). Martin C. Chang is often cited by papers focused on Breast Cancer Treatment Studies (16 papers), HER2/EGFR in Cancer Research (11 papers) and BRCA gene mutations in cancer (6 papers). Martin C. Chang collaborates with scholars based in Canada, United States and Spain. Martin C. Chang's co-authors include Rajesh Khanna, Lyanne C. Schlichter, Leonard K. Kaczmarek, Pamela J. Goodwin, Susan J. Done, William J. Joiner, Marguerite Ennis, Vuk Stambolic, Ryan J.O. Dowling and David R. McCready and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Martin C. Chang

65 papers receiving 2.1k citations

Peers

Countries citing papers authored by Martin C. Chang

Since Specialization

Citations

This map shows the geographic impact of Martin C. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin C. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin C. Chang more than expected).

Fields of papers citing papers by Martin C. Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin C. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin C. Chang. The network helps show where Martin C. Chang may publish in the future.

Co-authorship network of co-authors of Martin C. Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Martin C. Chang. A scholar is included among the top collaborators of Martin C. Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin C. Chang. Martin C. Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Crown-like structures in breast adipose tissue of breast cancer patients: associations with CD68 expression, obesity, metabolic factors and prognosis 2021 ·npj Breast Cancer ·Martin C. Chang, (unknown), Marguerite Ennis, Pamela J. Goodwin	30
2	Hep par 1 immunohistochemistry in glycogen-rich clear cell carcinoma of the breast 2019 ·Annals of Oncology ·Martin C. Chang, (unknown), Gillian Bethune	1
3	A phase II randomized clinical trial of the effect of metformin versus placebo on progression-free survival in women with metastatic breast cancer receiving standard chemotherapy 2019 ·The Breast ·Isabel Pimentel, Ana Elisa Lohmann, Marguerite Ennis, Ryan J.O. Dowling, David W. Cescon, Christine Elser, Kylea Potvin, Rashida Haq, Caroline Hamm, Martin C. Chang, Vuk Stambolic, Pamela J. Goodwin	73
4	Molecular Diagnosis of Placental Hydatidiform Mole: Innovation and Outcomes 2017 ·Journal of Obstetrics and Gynaecology Canada ·Terence J. Colgan, Abdul Noor, (unknown), Martin C. Chang, Elena Kolomietz	5
5	Tumor microenvironment determines response to a heat-activated thermosensitive liposome formulation of cisplatin in cervical carcinoma 2017 ·Journal of Controlled Release ·Yannan N. Dou, Naz Chaudary, Martin C. Chang, Michael Dunne, (unknown), David A. Jaffray, Michael Milosevic, Christine Allen	17
6	Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy 2017 ·The Breast ·Eileen Rakovitch, Sharon Nofech‐Mozes, Wedad Hanna, Rinku Sutradhar, Sumei Gu, Cindy Fong, Alan B. Tuck, Bruce Youngson, Naomi Miller, Susan J. Done, Martin C. Chang, Sandip Sengupta, Leela Elavathil, Prashant Jani, M. Bonin, Nafisha Lalani, Lawrence Paszat	14
7	Comparison of HER2 Dual-Color and Fluorescence In Situ Hybridization in Breast Cancer 2016 ·American Journal of Clinical Pathology ·(unknown), (unknown), (unknown), (unknown), María Fernanda Mendes, J. Brendan M. Mullen, Martin C. Chang	6
8	A Reappraisal of the Incidence of Placental Hydatidiform Mole Using Selective Molecular Genotyping 2016 ·International Journal of Gynecological Cancer ·Terence J. Colgan, Martin C. Chang, (unknown), Elena Kolomietz	10
9	Placental Molar Disease 2015 ·International Journal of Gynecological Pathology ·Elena Kolomietz, Georges Maire, (unknown), Martin C. Chang, (unknown), Jason Dodge, Terence J. Colgan	8
10	Detecting intratumoral heterogeneity in routine breast-HER2 testing: low yield of testing multiple blocks 2015 ·Annals of Diagnostic Pathology ·Gillian Bethune, J. Brendan Mullen, Martin C. Chang	4
11	PKA signaling drives mammary tumorigenesis through Src 2014 ·Oncogene ·Alexander G. Beristain, Sam D. Molyneux, Purna A. Joshi, Neil C. Pomroy, Marco A. Di Grappa, Martin C. Chang, Lawrence S. Kirschner, Gilbert G. Privé, Miguel Ángel Pujana, Rama Khokha	72
12	‘Genetic heterogeneity' in HER2/neu testing by fluorescence in situ hybridization: a study of 2522 cases 2012 ·Modern Pathology ·Martin C. Chang, Janet I. Malowany, (unknown), (unknown)	60
13	Testing for HER2 in Breast Cancer: Current Pathology Challenges Faced in Canada 2012 ·Current Oncology ·Wedad Hanna, Penny J. Barnes, Richard Berendt, Martin C. Chang, Anthony M. Magliocco, Anna Marie Mulligan, Huw Rees, Naomi Miller, Leela Elavathil, C. Blake Gilks, Norman M. Pettigrew, Dragana Pilavdzic, Sandip Sengupta	10
14	Long-Range PCR and Next-Generation Sequencing of BRCA1 and BRCA2 in Breast Cancer 2012 ·Journal of Molecular Diagnostics ·Hilmi Özçelik, Xuejiang Shi, Martin C. Chang, (unknown), (unknown), Nando Di Nicola, (unknown), (unknown), Aaron Goldman, Mark Dowar, Balram Sukhu, Rita A. Kandel, Kathy Siminovitch	45
15	XXI International Symposium on Glycoconjugates 2011 ·Glycoconjugate Journal ·Josephine Grass, Martin Pabst, Laura Neumann, Martin C. Chang, Friedrich Altmann, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
16	The evolving role of axillary lymph node fine‐needle aspiration in the management of carcinoma of the breast 2011 ·Cancer Cytopathology ·Martin C. Chang, Pavel Crystal, Terence J. Colgan	23
17	The impact of tissue block sampling on the detection of p53 signatures in fallopian tubes from women with BRCA 1 or 2 mutations (BRCA+) and controls 2010 ·Modern Pathology ·Karishma Mehra, Martin C. Chang, Ann K. Folkins, (unknown), Joema Felipe Lima, Liping Yuan, Mitra Mehrad, Shelley S. Tworoger, Christopher P. Crum, Aasia Saleemuddin	34
18	Regulation of Kv1.3 Channels in Activated Human T Lymphocytes by Ca<sup>2+</sup>-Dependent Pathways 2001 ·Cellular Physiology and Biochemistry ·Martin C. Chang, Rajesh Khanna, Lyanne C. Schlichter	9
19	hSK4/hIK1, a Calmodulin-binding KCa Channel in Human T Lymphocytes 1999 ·Journal of Biological Chemistry ·Rajesh Khanna, Martin C. Chang, William J. Joiner, Leonard K. Kaczmarek, Lyanne C. Schlichter	198
20	Acquisition of gamma camera and physiological data by computer. 1986 ·PubMed ·(unknown), Martin C. Chang, Bruce R. Line, Jeffrey A. Cooper, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact